| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |